Techdamentals
PFE · Pfizer Inc.Healthcare

What is Pfizer (PFE) stock worth?

Its intrinsic value, worked out four ways from Pfizer’s own reported numbers, against today’s price.
Fair value range
$31.79 – $38.85

Today’s price, $27.54, sits below the range. 22.0% below the $35.32 the four methods put it at.

UNDERVALUED
After hours $27.55 ▲ 0.04% (not used in the valuation)
This range was worked out on October 31, 2026 from the company's reported numbers. The price is live, and the verdict compares today's price with that range.
A fair value isn’t a one-time number. The valuation methods run on PFE’s reported numbers, which change with every quarterly earnings report, and this range is worked out again at least once a month. The price moves every day. So a stock that reads as cheap today can read as fair, or expensive, a few weeks from now. A free account keeps the latest range in front of you, and a phone alert tells you when the price moves into a part of the range you pick.

Inside PFE’s full analysis

The real sections, opened with your free account.

Why this verdict Free account

The 3 methods put Pfizer’s fair value around $35.32 a share.

The 3 methods, side by side Free account
Method 1
Method 2
Method 3
The business, in plain English 2 open

Is it growing? Over the last 3 years, Pfizer's sales have shrunk about 15% a year. In its latest quarter (Q3 '26), sales were about 0.4% lower than the same quarter a year earlier.

Does it make money? Yes. Of every dollar of sales, Pfizer keeps about 75 cents after making the product, 29 cents after running the business and 6 cents as profit after everything, tax included.

PFE’s latest earningsPfizer Inc.

Latest report: July to September 2026 (quarter ended Sep 27, 2026), reported Nov 3, 2026 before the open.

Earnings per share
$0.87Beat
$0.74 expected
Stock after report
−2.2%
S&P 500 +0.4%
Next report
Feb 2, 2027
expected date

Reported, not read yet. The company reported July to September 2026 results (quarter ended Sep 27, 2026) on Nov 3, 2026, before the open. The reading of its filing usually appears by the next morning. Until then the figures here are the ones already published.

July to September 2026, in numbers
Earnings per share
$0.87, above the $0.74 analysts expected.
Revenue
$17 billion, down 0.4% from a year ago and up 10% from the quarter before.
Profit
$3.2 billion. It keeps 20¢ of every sales dollar as profit, down from 21¢ a year ago.

From the company's quarterly statements through Sep 30, 2026.

The full read in the IV Calculator adds what the filing said that the headlines skipped, margins and cash for the quarter, how each part of the business did, and how PFE moved after its last eight reports.

See PFE’s full earnings read, free →
Not PFE? Value the stock you care about:
Educational tool, not investment advice. These are automated estimates from third-party data, impersonal and not tailored to anyone's situation. Data can be inaccurate and model assumptions can be wrong. We are not a registered investment adviser or broker-dealer. Always do your own research. See our methodology and terms.